Compare Aveanna Healthcare Holdings' momentum with hand-picked peers in outpatient and home health by scanning the 19 high quality undiscovered gems that may still be flying under most investors' radars.
Aveanna Healthcare Holdings appeals to investors who believe demand for in home pediatric and adult care will keep straining existing capacity and reward operators that can staff efficiently and secure stable reimbursement. The short term story focuses on whether robust service demand can be matched with enough caregivers without allowing wage pressure to erode the recent margin improvement.
The biggest swing factor over the next year appears to be execution on preferred payer relationships and rate pass throughs, set against wage inflation and caregiver retention risk. Recent share price and EPS momentum do not materially change those core operational questions; they instead raise the bar for consistent delivery.
Recent commentary around Aveanna Healthcare Holdings has centered on the sharp improvement in earnings over the past year and a higher consensus EPS estimate. That connects directly to the key catalyst investors focus on: evidence that the preferred payer strategy and operational adjustments are contributing to cleaner, repeatable profit rather than one off benefits.
This same backdrop keeps the main risks in view. Earnings are forecast by analysts to decline over the next three years, interest costs are not well covered, and the group carries about US$1.47b of variable rate debt. Any setback in reimbursement rates, payer mix, or staffing efficiency could have a greater impact now that expectations have reset higher.
Aveanna Healthcare Holdings' current analyst framework ties the story to concrete numbers rather than just sentiment. Analysts build their view on revenue expanding by 7.0% a year over the next three years, while profit margins move from 10.6% today to 5.7% in 2029. That mix pairs solid top line growth with thinner profitability, which matters for anyone trying to judge how much of the demand for home care might ultimately show up in future earnings.
On earnings, the consensus points to US$274.8 million today versus a forecast of US$180.3 million in 2029. That is a projected decline of about US$94.5 million, not growth. The more optimistic end of the range sits at US$204.7 million, so there is visible disagreement on how much margin compression and execution risk might filter through. For readers tracking Aveanna Healthcare Holdings as a margin turnaround idea rather than a pure volume story, that gap between the bullish and base case scenarios is an important signal to keep in view.
Aveanna Healthcare Holdings' narrative projects US$3.2b revenue and US$180.3 million earnings by 2029. This assumes 7.0% yearly revenue growth and an earnings decrease of about US$94.5 million from US$274.8 million today.
Analysts then connect those operating assumptions to valuation through the P/E multiple. The stock would need to trade on 25.0x the projected 2029 earnings, compared with about 11.3x today and slightly above the cited 24.1x for the broader US healthcare group. That means the current thesis does not just rest on Aveanna Healthcare Holdings delivering the forecast profit pool. It also leans on investors being willing to ascribe a meaningfully richer earnings multiple than they do at present.
The same models factor in share count too. Forecasts call for the number of shares outstanding to rise by 4.46% a year over the next three years. For existing holders, that projected dilution makes the earnings trajectory and the assumed future P/E even more critical, because more shares spread those future profits across a wider base.
Uncover why Aveanna Healthcare Holdings' fair value indicates an 11% potential upside to its current price that could narrow quickly.
One alternate angle around Aveanna Healthcare focuses less on EPS momentum and more on how quickly free cash flow could be redeployed once leverage trends closer to the sub 3x target. The most optimistic analysts already modeled about US$3.3b revenue and US$202.9 million earnings for 2029 before this recent 61.1% year to date move. You may want to compare that pre news optimism with your own view on how this latest performance could shift expectations.
Explore 2 other Aveanna Healthcare Holdings fair value estimates, including one that suggests as much as 114% upside from the current price!
Don't just follow the ticker; dig into the data and build a conviction that's truly your own.
Once you have formed a view on Aveanna Healthcare Holdings, it can help to widen the lens and compare it with other businesses that share similar strengths or offer different risk and reward profiles. The Simply Wall St Screener lets you filter by balance sheet quality, valuation, income potential, and more so you can build a watchlist that actually fits your goals.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com